These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30794672)

  • 1. Effects of high-volume online mixed-hemodiafiltration on anemia management in dialysis patients.
    Pedrini LA; Zawada AM; Winter AC; Pham J; Klein G; Wolf M; Feuersenger A; Ruggiero P; Feliciani A; Barbieri C; Gauly A; Canaud B; Stuard S
    PLoS One; 2019; 14(2):e0212795. PubMed ID: 30794672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed hemodiafiltration reduces erythropoiesis stimulating agents requirement in dialysis patients: a prospective randomized study.
    Pedrini LA; Comelli M; Ruggiero P; Feliciani A; Manfrini V; Cozzi G; Castellano A; Pezzotta M; Gatti G; Arazzi M; Auriemma L; di Benedetto A; Stuard S
    J Nephrol; 2020 Oct; 33(5):1037-1048. PubMed ID: 32036610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-volume online haemodiafiltration improves erythropoiesis-stimulating agent (ESA) resistance in comparison with low-flux bicarbonate dialysis: results of the REDERT study.
    Panichi V; Scatena A; Rosati A; Giusti R; Ferro G; Malagnino E; Capitanini A; Piluso A; Conti P; Bernabini G; Migliori M; Caiani D; Tetta C; Casani A; Betti G; Pizzarelli F
    Nephrol Dial Transplant; 2015 Apr; 30(4):682-9. PubMed ID: 25385719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients.
    Marcelli D; Bayh I; Merello JI; Ponce P; Heaton A; Kircelli F; Chazot C; Di Benedetto A; Marelli C; Ladanyi E; Kroczak M; Stuard S; Grassmann A; Scatizzi L; Brand K; Canaud B
    Kidney Int; 2016 Jul; 90(1):192-202. PubMed ID: 27178833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of incident patients on high-volume online hemodiafiltration compared to low-volume online hemodiafiltration and high-flux hemodialysis.
    Imamović G; Hrvačević R; Kapun S; Marcelli D; Bayh I; Grassmann A; Scatizzi L; Maslovarić J; Canaud B
    Int Urol Nephrol; 2014 Jun; 46(6):1191-200. PubMed ID: 24057682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized anemia management in a dialysis facility - long-term utility as a single-center quality improvement experience
.
    Gaweda AE; Jacobs AA; Aronoff GR; Brier ME
    Clin Nephrol; 2018 Oct; 90(4):276-285. PubMed ID: 30049300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Convection Affects Serum β2 Microglobulin and C-Reactive Protein but Not Erythropoietin Requirement following Post-Dilutional Hemodiafiltration.
    Movilli E; Camerini C; Gaggia P; Zubani R; Feller P; Salviani C; Facchini A; Cancarini G
    Am J Nephrol; 2015; 41(6):494-501. PubMed ID: 26278270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation of clinical and laboratory features in chronic dialysis patients treated with high-flux hemodialysis after switching to online hemodiafiltration.
    Orasan RA; Patiu IM; Anghel D; Bejan C; Iosub L; Totolici C; Pop M; Turcea C; Teodoru C; Orasan OH; Kacso IM; Gherman Caprioara M
    Int Urol Nephrol; 2013 Oct; 45(5):1415-22. PubMed ID: 23212146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of anemia in hemodialysis patients treated by hemodiafiltration with high-volume on-line-prepared substitution fluid.
    Bonforte G; Grillo P; Zerbi S; Surian M
    Blood Purif; 2002; 20(4):357-63. PubMed ID: 12169845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to erythropoiesis stimulating agents in patients treated with online hemodiafiltration and ultrapure low-flux hemodialysis: results from a randomized controlled trial (CONTRAST).
    van der Weerd NC; Den Hoedt CH; Blankestijn PJ; Bots ML; van den Dorpel MA; Lévesque R; Mazairac AH; Nubé MJ; Penne EL; ter Wee PM; Grooteman MP;
    PLoS One; 2014; 9(4):e94434. PubMed ID: 24743493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial.
    Locatelli F; Altieri P; Andrulli S; Sau G; Bolasco P; Pedrini LA; Basile C; David S; Feriani M; Nebiolo PE; Ferrara R; Casu D; Logias F; Tarchini R; Cadinu F; Passaghe M; Fundoni G; Villa G; Di Iorio BR; Zoccali C
    Nephrol Dial Transplant; 2012 Sep; 27(9):3594-600. PubMed ID: 22622452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why choose high volume online post-dilution hemodiafiltration?
    Basile C; Davenport A; Blankestijn PJ
    J Nephrol; 2017 Apr; 30(2):181-186. PubMed ID: 27586123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia management trends in hospital-based dialysis centers (HBDCs), 2010 to 2013.
    Coritsidis GN; Maglinte GA; Acharya A; Saxena A; Chang CL; Hill J; Gitlin M; Lafayette RA
    Clin Ther; 2014 Mar; 36(3):408-18. PubMed ID: 24582713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related Quality of Life in Patients Receiving Hemodialysis.
    Freburger JK; Ellis AR; Wang L; Butler AM; Kshirsagar AV; Winkelmayer WC; Brookhart MA
    Am J Kidney Dis; 2016 Feb; 67(2):271-82. PubMed ID: 26508682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized anemia management reduces hemoglobin variability in hemodialysis patients.
    Gaweda AE; Aronoff GR; Jacobs AA; Rai SN; Brier ME
    J Am Soc Nephrol; 2014 Jan; 25(1):159-66. PubMed ID: 24029429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of mid-week hemoglobin measurement for anemia management in patients undergoing hemodialysis: a retrospective cohort study.
    Bae SY; Jeon JW; Kim SH; Baek CH; Jang JW; Yang WS; Kim SB; Park SK; Lee SK; Kim H
    BMC Nephrol; 2019 Aug; 20(1):295. PubMed ID: 31375077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and methodology of the impact of HemoDiaFIlTration on physical activity and self-reported outcomes: a randomized controlled trial (HDFIT trial) in Brazil.
    Pecoits-Filho R; Larkin JW; Poli-de-Figueiredo CE; Cuvello Neto AL; Barra AB; Canhada S; de Campos LG; Woehl J; Gonçalves PB; Han H; de Moraes TP; Raimann JG; Canziani MEF;
    BMC Nephrol; 2019 Mar; 20(1):98. PubMed ID: 30894141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of clinical outcomes in dialysis: No convincing superiority in dialysis efficacy using hemodiafiltration vs high-flux hemodialysis.
    Abdelsalam M; Demerdash TM; Assem M; Awais M; Shaheen M; Sabri A; Alanany H; Kashgary A; Alsuwaida A
    Ther Apher Dial; 2021 Aug; 25(4):483-489. PubMed ID: 32243070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-line hemodiafiltration as routine treatment of end-stage renal failure: why pre- or mixed dilution mode is necessary in on-line hemodiafiltration today?
    Canaud B; Lévesque R; Krieter D; Desmeules S; Chalabi L; Moragués H; Morena M; Cristol JP
    Blood Purif; 2004; 22 Suppl 2():40-8. PubMed ID: 15655323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.